Non-invasive diagnosis of clinically significant portal hypertension (CSPH) has important prognostic and therapeutic implications for patients with compensated advanced chronic liver disease (cACLD). We aimed to validate and improve the available algorithms for the CSPH diagnosis by evaluating spleen stiffness measurement (SSM) in patients with cACLD.
Dajti, E., Ravaioli, F., Marasco, G., Alemanni, L.V., Colecchia, L., Ferrarese, A., et al. (2022). A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease. THE AMERICAN JOURNAL OF GASTROENTEROLOGY, Publish Ahead of Print, 1-30 [10.14309/ajg.0000000000001887].
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease
Dajti, EltonCo-primo
;Ravaioli, FedericoCo-primo
;Marasco, Giovanni;Alemanni, Luigina Vanessa;Colecchia, Luigi;Vestito, Amanda;Renzulli, Matteo;Golfieri, Rita;Festi, Davide;
2022
Abstract
Non-invasive diagnosis of clinically significant portal hypertension (CSPH) has important prognostic and therapeutic implications for patients with compensated advanced chronic liver disease (cACLD). We aimed to validate and improve the available algorithms for the CSPH diagnosis by evaluating spleen stiffness measurement (SSM) in patients with cACLD.| File | Dimensione | Formato | |
|---|---|---|---|
|
2022_A_combined_Baveno_AM.pdf
accesso aperto
Tipo:
Postprint
Licenza:
Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione
3.85 MB
Formato
Adobe PDF
|
3.85 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
